🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The HS-RISE study aims to assess real-world HS treatment outcomes and patte...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2025-12-12
Trial ID
NCT07282015
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested
The purpose of this study was to evaluate the efficacy, safety, and tolerab...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-07-21
Trial ID
NCT04732117
Treatments Being Tested
This multicenter, randomized, double-blind, active-controlled study aims to...
Status
Active Not Recruiting
Location
Dermatology Hospital of Shandong First Medical University (Shandong Provincial Hospitial of Dermatology)
Start Date
2025-05-27
Trial ID
NCT06945107
Treatments Being Tested
ANIMA-R is an observational, prospective, non-interventional, multicenter s...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2024-07-26
Trial ID
NCT06517732
Treatments Being Tested
Psoriasis is a chronic inflammatory skin disease characterized by scaly ind...
Status
Completed
Location
South Valley Hospitals
Start Date
2024-12-01
Trial ID
NCT06729463
Treatments Being Tested
The purpose of the study is to determine whether, in patients with moderate...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-07
Trial ID
NCT00941031
This study assessed efficacy of secukinumab, compared to ustekinumab, in pa...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-26
Trial ID
NCT02074982
Treatments Being Tested
This study was a retrospective non-interventional cohort study with seconda...
Status
Completed
Location
Novartis Pharma K.K.
Start Date
2022-10-17
Trial ID
NCT06600009
Treatments Being Tested
Biologics such as secukinumab are currently the most effective treatment op...
Status
Completed
Location
AZ Maria Middelares
Start Date
2018-03-22
Trial ID
NCT04080661
Treatments Being Tested